Search research articles
Contact Us
Filters
Showing results (51-60 of 90) with videos related to
Page
of 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 14, 2015
Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study
Robert Orenstein, Erik Dubberke, Robert Hardi, et al.
Mayo Clinic Proceedings
|
August 19, 2020
Research Response to SARS-CoV-2/COVID-19
Charles D Burger, Amanda E Mikhail, Robert Orenstein, et al.
Inflammatory Bowel Diseases
|
January 25, 2025
Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), for the Prevention of Recurrent Clostridioides difficile Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLS
Jessica R Allegretti, Paul Feuerstadt, Whitfield L Knapple, et al.
BMC Infectious Diseases
|
May 25, 2011
Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009
Timothy C Olson, Tim Bongartz, Cynthia S Crowson, et al.
Infectious Diseases and Therapy
|
June 12, 2026
Efficacy Outcomes of Fecal Microbiota, Live-jslm in Preventing Recurrent Clostridioides difficile Infection from Seven Clinical Studies
Teena Chopra, Daniel Van Handel, Brian Baggott, et al.
Open Forum Infectious Diseases
|
June 14, 2024
Deep Sternal Wound Infection Caused by <i>Rhizopus</i> Species After Coronary Artery Bypass Graft
Cody A Cunningham, Thomas E Grys, Francis X Downey, et al.
Therapeutic Advances in Gastroenterology
|
June 19, 2023
Safety of fecal microbiota, live-jslm (REBYOTA<sup>™</sup>) in individuals with recurrent <i>Clostridioides difficile</i> infection: data from five prospective clinical trials
Christine Lee, Thomas Louie, Lindy Bancke, et al.
The Journal of Infection
|
April 11, 2013
The impact of early and brief corticosteroids on the clinical course of primary pulmonary coccidioidomycosis
Natalya Azadeh, Yu-Hui H Chang, Shimon Kusne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection
Roberto L Patron, Carlos A Hartmann, Sorcha Allen, et al.
Mycopathologia
|
August 6, 2016
Coccidioidomycosis in Patients with Selected Solid Organ Cancers: A Case Series and Review of Medical Literature
Colin Fitterer, Zachary Berg, Thorvardur R Halfdanarson, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 90) with videos related to
Sort By:
Page
of 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 14, 2015
Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study
Robert Orenstein, Erik Dubberke, Robert Hardi, et al.
Mayo Clinic Proceedings
|
August 19, 2020
Research Response to SARS-CoV-2/COVID-19
Charles D Burger, Amanda E Mikhail, Robert Orenstein, et al.
Inflammatory Bowel Diseases
|
January 25, 2025
Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), for the Prevention of Recurrent Clostridioides difficile Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLS
Jessica R Allegretti, Paul Feuerstadt, Whitfield L Knapple, et al.
BMC Infectious Diseases
|
May 25, 2011
Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009
Timothy C Olson, Tim Bongartz, Cynthia S Crowson, et al.
Infectious Diseases and Therapy
|
June 12, 2026
Efficacy Outcomes of Fecal Microbiota, Live-jslm in Preventing Recurrent Clostridioides difficile Infection from Seven Clinical Studies
Teena Chopra, Daniel Van Handel, Brian Baggott, et al.
Open Forum Infectious Diseases
|
June 14, 2024
Deep Sternal Wound Infection Caused by <i>Rhizopus</i> Species After Coronary Artery Bypass Graft
Cody A Cunningham, Thomas E Grys, Francis X Downey, et al.
Therapeutic Advances in Gastroenterology
|
June 19, 2023
Safety of fecal microbiota, live-jslm (REBYOTA<sup>™</sup>) in individuals with recurrent <i>Clostridioides difficile</i> infection: data from five prospective clinical trials
Christine Lee, Thomas Louie, Lindy Bancke, et al.
The Journal of Infection
|
April 11, 2013
The impact of early and brief corticosteroids on the clinical course of primary pulmonary coccidioidomycosis
Natalya Azadeh, Yu-Hui H Chang, Shimon Kusne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection
Roberto L Patron, Carlos A Hartmann, Sorcha Allen, et al.
Mycopathologia
|
August 6, 2016
Coccidioidomycosis in Patients with Selected Solid Organ Cancers: A Case Series and Review of Medical Literature
Colin Fitterer, Zachary Berg, Thorvardur R Halfdanarson, et al.
Page
of 9